News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by Clubber on Friday June 11, 2021 @10:43AM (#27474047)
Wouldn't charging $56k / year for a drug that not only doesn't work, but has a high chance to induce brain swelling be considered fraud?
[ Parent | on HN ]

There are no comments on this comment yet.